SHANGHAI and JERSEY CITY, N.J., Sept. 2, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) has approved BILDYOS® (denosumab-nxxp) injection 60 mg/mL and BILPREVDA® (denosumab-nxxp) injection 120 mg/1.7 mL, biosimilars to PROLIA (denosumab) and XGEVA (denosumab), respectively, for all indications of...
SHENZHEN, China, Sept. 2, 2025 /PRNewswire/ -- This September, Anycubic celebrates its 10th anniversary, a milestone that marks a decade of technological advancement and a shared...
Vermiculus Financial Technology, a leading provider of modern technology for exchanges, clearing houses, and CSDs, has engaged with GreySpark Partners to release a new...